HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nicola Miller Selected Research

Rectal Neoplasms (Rectal Cancer)

2/2013miRNA expressions in rectal cancer as predictors of response to neoadjuvant chemoradiation therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nicola Miller Research Topics

Disease

49Breast Neoplasms (Breast Cancer)
01/2022 - 11/2007
41Neoplasms (Cancer)
01/2022 - 11/2007
7Colorectal Neoplasms (Colorectal Cancer)
04/2022 - 04/2010
3Carcinogenesis
01/2022 - 09/2010
3Prostatic Neoplasms (Prostate Cancer)
07/2015 - 06/2011
3Ovarian Neoplasms (Ovarian Cancer)
06/2014 - 08/2008
2Disease Progression
01/2022 - 01/2009
2Triple Negative Breast Neoplasms
06/2014 - 04/2011
1Neoplasm Metastasis (Metastasis)
01/2022
1Circulating Neoplastic Cells
01/2022
1Ductal Carcinoma
10/2021
1Noninfiltrating Intraductal Carcinoma (DCIS)
02/2016
1Genetic Risk Score
05/2015
1Familial Breast Cancer
02/2015
1Hypersensitivity (Allergy)
12/2013
1Colonic Neoplasms (Colon Cancer)
12/2013
1Rectal Neoplasms (Rectal Cancer)
02/2013
1Esophageal Neoplasms (Esophageal Cancer)
11/2009
1Hepatoblastoma
08/2008
1Neuroblastoma
08/2008

Drug/Important Bio-Agent (IBA)

33MicroRNAs (MicroRNA)IBA
04/2022 - 01/2008
17Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2007
17Estrogen ReceptorsIBA
12/2017 - 08/2009
7Proteins (Proteins, Gene)FDA Link
01/2022 - 08/2009
7Hormones (Hormone)IBA
10/2021 - 08/2009
6Progesterone Receptors (Progesterone Receptor)IBA
10/2021 - 01/2009
4Phenobarbital (Luminal)FDA Link
07/2020 - 01/2009
4Biological ProductsIBA
01/2019 - 04/2011
43' Untranslated Regions (3' UTR)IBA
01/2016 - 01/2014
4Estrogens (Estrogen)FDA Link
01/2015 - 01/2008
3Epidermal Growth Factor (EGF)IBA
01/2022 - 10/2021
3DNA (Deoxyribonucleic Acid)IBA
08/2020 - 01/2015
3Transcription Factors (Transcription Factor)IBA
01/2020 - 04/2013
3Genetic Markers (Genetic Marker)IBA
05/2015 - 04/2011
3ErbB-2 ReceptorIBA
01/2014 - 01/2009
3Tumor Biomarkers (Tumor Markers)IBA
01/2014 - 10/2010
2Circulating MicroRNAIBA
07/2020 - 07/2015
2LuciferasesIBA
06/2014 - 04/2013
2Messenger RNA (mRNA)IBA
07/2013 - 04/2011
2RNA (Ribonucleic Acid)IBA
01/2013 - 11/2009
2Gonadotropin-Releasing Hormone (GnRH)FDA Link
11/2011 - 06/2011
2LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA
06/2011 - 08/2008
1Cell-Free Nucleic AcidsIBA
01/2022
1cytidylyl-(3'-5')-cytidine (CpC)IBA
02/2015
1ChromatinIBA
01/2015
1EstroneFDA Link
05/2014
1GlucuronidesIBA
05/2014
1Cytochrome P-450 CYP3AIBA
05/2014
1Deoxyribonucleases (DNase)FDA Link
12/2013
1DNA-Binding Proteins (DNA Binding Protein)IBA
12/2013
1Complement System Proteins (Complement)IBA
06/2013
1Cyclin D1IBA
04/2013
1Formaldehyde (Formol)FDA Link
02/2013
1ParaffinIBA
02/2013
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2011
1P-2 (P 2)IBA
02/2011
1ErbB Receptors (EGF Receptor)IBA
01/2011
1Transforming Growth Factor-beta Type I ReceptorIBA
01/2010
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
08/2009
1ProgesteroneFDA LinkGeneric
01/2009
1Estrogen Receptor alphaIBA
01/2008

Therapy/Procedure

7Therapeutics
01/2022 - 01/2009
6Neoadjuvant Therapy
01/2022 - 11/2009
5Drug Therapy (Chemotherapy)
01/2022 - 11/2014
1Radiotherapy
10/2021
1Perioperative Period
03/2010
1Chemoradiotherapy
11/2009